AGNG


Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2022

Key Information As of 07/16/24

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $60.49 million
NAV $31.02
Fact Sheet View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 07/16/24

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 1,950,000
Number of Holdings 84
30-Day Median Bid-Ask Spread 0.33%

Distributions As of 07/16/24

30-Day SEC Yield 0.97%
Distribution Frequency Semi-Annually

ETF Prices As of 07/16/24

NAV $31.02 Daily Change $0.14 0.45%
Market Price $31.09 Daily Change $0.19 0.61%

Performance History

As of recent month & quarter-end (06/30/24)
As of recent month & quarter-end (06/30/24)
Fund NAV Market Price Index
1 Year 8.93% 9.04% 9.26%
3 Years 0.35% 0.31% 0.56%
5 Years 7.90% 7.91% 8.14%
Since Inception 9.54% 9.83% 9.83%
1 Year 8.93% 9.04% 9.26%
3 Years 0.35% 0.31% 0.56%
5 Years 7.90% 7.91% 8.14%
Since Inception 9.54% 9.83% 9.83%
Year-to-Date 5.80% 6.13% 5.90%
1 Month 1.77% 1.60% 1.77%
3 Months 0.68% 0.25% 0.72%
Since Inception 110.18% 114.76% 114.65%
Year-to-Date 5.80% 6.13% 5.90%
1 Month 1.77% 1.60% 1.77%
3 Months 0.68% 0.25% 0.72%
Since Inception 110.18% 114.76% 114.65%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 07/16/24

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.50 LLY ELI LILLY & CO 2516152 941.60 2,247 2,115,775.20
3.48 AMGN AMGEN INC 2023607 333.14 6,322 2,106,111.08
3.36 REGN REGENERON PHARMACEUTICALS 2730190 1,094.99 1,855 2,031,206.45
3.31 WELL WELLTOWER INC BYVYHH4 105.94 18,888 2,000,994.72
3.20 BSX BOSTON SCIENTIFIC CORP 2113434 78.14 24,795 1,937,481.30
3.20 NOVOB DC NOVO NORDISK A/S-B BP6KMJ1 141.44 13,681 1,935,091.90
3.19 AZN ASTRAZENECA PLC-SPONS ADR 2989044 78.59 24,577 1,931,506.43
3.16 4519 JP CHUGAI PHARMA CO 6196408 38.24 50,005 1,911,979.07
3.08 ALC SW ALCON INC BJT1GR5 89.71 20,789 1,864,977.48
2.88 RO SW ROCHE HOLDING AG-BR 7108918 317.19 5,495 1,742,945.31
2.86 JNJ JOHNSON & JOHNSON 2475833 151.01 11,470 1,732,084.70
2.85 ABBV ABBVIE INC B92SR70 169.20 10,188 1,723,809.60
2.72 SYK STRYKER CORP 2853688 333.43 4,928 1,643,143.04
2.71 EW EDWARDS LIFESCIENCES CORP 2567116 87.73 18,670 1,637,919.10
2.68 MDT MEDTRONIC PLC BTN1Y11 78.10 20,768 1,621,980.80
2.58 UCB BB UCB SA 5596991 155.19 10,047 1,559,186.85
2.52 068270 KS CELLTRION INC B0C5YV1 136.22 11,194 1,524,856.74
2.37 BMY BRISTOL-MYERS SQUIBB CO 2126335 41.20 34,735 1,431,082.00
2.34 DXCM DEXCOM INC B0796X4 116.06 12,219 1,418,137.14
2.21 4543 JP TERUMO CORP 6885074 17.40 76,985 1,339,270.56
1.88 ZBH ZIMMER BIOMET HO 2783815 107.46 10,565 1,135,314.90
1.82 VTR VENTAS INC 2927925 53.10 20,728 1,100,656.80
1.74 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 128.35 8,204 1,052,968.75
1.62 4503 JP ASTELLAS PHARMA INC 6985383 10.44 93,667 977,451.28
1.54 SOON SW SONOVA HOLDING AG-REG 7156036 302.68 3,067 928,315.18
1.50 GMAB DC GENMAB A/S 4595739 266.56 3,411 909,221.99
1.41 SDZ SW SANDOZ GROUP AG BLPLD38 38.39 22,263 854,740.18
1.31 UTHR UNITED THERAPEUTICS CORP 2430412 328.19 2,422 794,876.18
1.25 COH AU COCHLEAR LTD 6211798 224.46 3,373 757,094.86
1.25 NBIX NEUROCRINE BIOSC 2623911 147.45 5,119 754,796.55
1.24 BGNE BEIGENE LTD-ADR BYYWPW6 152.92 4,921 752,519.32
1.22 INCY INCYTE CORP 2471950 64.00 11,551 739,264.00
1.20 PODD INSULET CORP B1XGNW4 201.39 3,603 725,608.17
1.07 3692 HK HANSOH PHARMACEU BJYKB72 2.11 306,243 647,162.12
1.03 DVA DAVITA INC 2898087 137.72 4,532 624,147.04
1.03 SN/ LN SMITH & NEPHEW PLC 0922320 13.76 45,262 622,656.50
0.99 FME GR FRESENIUS MEDICAL CARE AG 5129074 39.22 15,187 595,617.22
0.92 TFX TELEFLEX INC 2881407 229.28 2,417 554,169.76
0.83 DEMANT DC DEMANT A/S BZ01RF1 43.54 11,594 504,818.33
0.77 EXAS EXACT SCIENCES CORP 2719951 49.67 9,377 465,755.59
0.75 OHI OMEGA HEALTHCARE 2043274 35.70 12,670 452,319.00
0.68 ENSG ENSIGN GROUP INC/THE B1YWPP8 139.86 2,927 409,370.22
0.64 AMP IM AMPLIFON SPA B14NJ71 33.09 11,720 387,861.62
0.63 BPMC BLUEPRINT MEDICINES CORP BWY52P3 120.50 3,165 381,382.50
0.60 HALO HALOZYME THERAPEUTICS INC 2975098 55.10 6,569 361,951.90
0.59 EXEL EXELIXIS INC 2576941 22.76 15,663 356,489.88
0.56 YPSN SW YPSOMED HOLDING AG-REG B02SWN8 478.79 701 335,635.04
0.53 GKOS GLAUKOS CORP BYMWL19 125.69 2,556 321,263.64
0.44 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 48.05 5,588 268,503.40
0.43 MMSI MERIT MEDICAL SYSTEMS INC 2580555 87.06 2,996 260,831.76
0.40 PHM SM PHARMA MAR SA BMW2GT8 41.82 5,776 241,546.39
0.40 SILK SILK ROAD MEDICAL INC BGHVXJ7 27.07 8,846 239,461.22
0.40 AGL AGILON HEALTH INC BLR4TK4 7.46 32,084 239,346.64
0.39 NHC NATIONAL HEALTHCARE CORP 2139731 126.51 1,880 237,838.80
0.39 MNKD MANNKIND CORP BF081J4 6.00 39,265 235,590.00
0.39 NVCR NOVOCURE LTD BYSS4X4 19.28 12,110 233,480.80
0.36 ITGR INTEGER HOLDINGS CORP BD06LM7 124.77 1,730 215,852.10
0.36 GN DC GN STORE NORD A/S 4501093 27.50 7,811 214,812.89
0.35 NHI NATL HEALTH INVESTORS INC 2626125 73.65 2,864 210,933.60
0.35 DNLI DENALI THERAPEUTICS INC BD2B4V0 23.94 8,802 210,719.88
0.34 EMBC EMBECTA CORP BMXWYR1 13.20 15,536 205,075.20
0.34 SBRA SABRA HEALTH CAR B5NLBP6 16.61 12,234 203,206.74
0.32 BKD BROOKDALE SR B0PZN33 7.63 25,360 193,496.80
0.32 LTC LTC PROPERTIES INC 2498788 36.37 5,316 193,342.92
0.31 TBPH THERAVANCE BIOPHARMA INC BMNDK09 9.99 18,861 188,421.39
0.31 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 10.72 17,387 186,454.74
0.30 ACAD ACADIA PHARMACEU 2713317 18.62 9,825 182,941.50
0.30 AMED AMEDISYS INC 2024332 97.74 1,829 178,766.46
0.30 CSH-U CN CHARTWELL RETIRE B8S8C94 9.58 18,655 178,671.83
0.29 AED BB AEDIFICA B1G5XP1 64.51 2,745 177,087.12
0.28 9229 JP SUNWELS CO LTD BNTYNB5 15.88 10,734 170,422.85
0.28 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.36 475,024 169,739.43
0.28 LIVN LIVANOVA PLC BYMT0J1 53.97 3,119 168,332.43
0.28 8086 JP NIPRO CORP 6641599 8.16 20,454 166,822.72
0.27 ALEC ALECTOR INC BJ4LDC4 6.08 26,956 163,892.48
0.26 RYM NZ RYMAN HEALTHCARE LTD 6161525 2.48 62,560 154,988.10
0.25 853 HK MICROPORT SCIENTIFIC CORP B676TW7 0.68 220,702 150,094.15
0.24 EKTAB SS ELEKTA AB-B SHS B0M42T2 6.29 23,060 145,060.13
0.24 ATEC ALPHATEC HOLDINGS INC BD60BG7 11.87 12,203 144,849.61
0.24 OTHER PAYABLE & RECEIVABLES 1.00 142,397 142,396.77
0.23 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 0.57 245,689 139,711.34
0.23 145720 KS DENTIUM CO LTD BF07GJ6 75.73 1,810 137,064.79
0.23 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.18 750,292 136,452.54
0.09 2500 HK VENUS MEDTECH -H BL6V047 0.54 102,940 55,570.55
0.07 CASH 1.00 44,952 44,952.21
0.00 RADIUS HEALTH INC - CVR 2KFF9T0 0.00 19,104 0.02
0.00 CANADIAN DOLLAR 1.00 0 -0.01
0.00 SWISS FRANC 1.12 -1,261 -1,407.72
0.00 JAPANESE YEN 0.01 -301,614 -1,901.79
0.00 EURO 1.09 -2,383 -2,592.24
Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 06/30/24

Sector Weight (%)
Health Care 92.5
Real Estate 7.2
Consumer Discretionary 0.4

Source: new windowAltaVista Research, LLC

Industry Weight (%)
Health Care 45.3
Biotechnology 24.9
Pharmaceuticals 24.0
Real Estate 5.4
Consumer products 0.4

Source: new windowAltaVista Research, LLC

Country Weight (%)
United States 54.0
Switzerland 11.3
Japan 7.4
Denmark 6.1
Britain 4.9
China 3.4
Belgium 2.9
Ireland 2.8
South Korea 2.7
Australia 1.3
Germany 1.0
Other 2.2

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 07/16/24

Return on Equity 13.20%
Weighted Avg. Market Cap 114,621 M
2023 2024
Price-to-earnings 27.16 26.48
Price-to-book value 3.63 3.36

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 06/30/24

Versus Beta
S&P 500 0.72
NASDAQ-100 0.49
MSCI EAFE 0.77
MSCI Emg. Mkts 0.53
Standard Deviation 15.80%

Source: new windowAltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.